Kevin L Mensink insider trades: Entellus Medical (ENTL) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kevin reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 20, 2017 | ENTL | ↓ Sell | 2,500 | $19.00 | $48K | Direct | Oct 24, 2017 (4d) |
| Oct 16, 2017 | ENTL | ↓ Sell | 10,000 | $18.29 | $183K | Direct | Oct 18, 2017 (2d) |
| Sep 1, 2016 | ENTL | ↓ Sell | 8,000 | $18.39 | $147K | Direct | Sep 1, 2016 (0d) |
| Aug 1, 2016 | ENTL | ↓ Sell | 8,100 | $17.63 | $143K | Direct | Aug 2, 2016 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Kevin L Mensink's insider trades
Kevin L Mensink is Vice President, Marketing at Entellus Medical (ENTL). Since Aug 1, 2016, Kevin has reported no open-market purchases and 4 sales worth $520K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (3 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ENTL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.